(Q28488158)
Statements
Polymorphisms in the F8 gene and MHC-II variants as risk factors for the development of inhibitory anti-factor VIII antibodies during the treatment of hemophilia a: a computational assessment (English)
0 references
2013
0 references
9
0 references
5
0 references
e1003066
0 references
16 May 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference